Forever young: the firms keeping people active

Past performance is not a reliable guide to the future. However, investors’ portfolios can benefit from UK shares that have consistently and substantially outperformed the stockmarket. One of the best

ASIA-PACIFIC 2025

Thought-provoking culture, insightful science and inspirational snippets to bring you up to date on all things uplifting, hopeful and happy-making

Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say

Picking through a murky market outlook for the rest of 2025

Why stocks armed with patents can outperform